🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for Naevi

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study NCT05463757n/a8 sites📍 Nijmegen📍 Maastricht📍 Amsterdam Maastricht University Medical Center · Tests: Vismodegib, Sonidegib Clonal Hematopoiesis Chemotherapy and Radiation Effects Study NCT07675967n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma NCT00040352n/a2 sites📍 Bethesda📍 Bethesda National Cancer Institute (NCI) Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision NCT02280889n/a1 site📍 Zurich University Children's Hospital, Zurich Neurocutaneous Melanocytosis Registry NCT04548817n/a2 sites📍 Boston📍 New York Memorial Sloan Kettering Cancer Center InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT NCT05171894Phase 25 sites📍 Irvine📍 San Diego📍 Miami Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Tests: Hemopfin+Green Light, Vehicle+Green Light Genetic Basis of Melanocytic Nevi NCT03054584n/a1 site📍 Sacramento University of California, Davis · Tests: Collecting Nevi CongenItal Naevus Cohort for Longitudinal Evaluation NCT06828822NA16 sites📍 Nice📍 Nice📍 Marseille Nantes University Hospital · Tests: Neurodevelopmental assessment, Meeting with the parents, Patient quality of life assessment Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care NCT07349940NA5 sites📍 Brno📍 Olomouc📍 Pilsen Institute of Health Information and Statistics of the Czech… · Tests: Intervention with telemedicine tool Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling NCT06330350n/a1 site📍 Maastricht Maastricht University Medical Center · Tests: Qualitative interview Lymphatic Anomalies Registry for the Assessment of Outcome Data NCT02399527n/a1 site📍 Boston Boston Children's Hospital The Cancer of the Pancreas Screening-5 CAPS5)Study NCT02000089Phase 39 sites📍 New Haven📍 Baltimore📍 Boston Johns Hopkins University · Tests: Secretin, MRI, Tumor marker gene test with CA19-9 Precision Medicine for L/GCMN and Melanoma 2 NCT06605443n/a3 sites📍 Barcelona📍 Barcelona📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Breath analyzer, Skin patch, Liquid biopsy Understanding the Transition from Normal Melanocytes to Nevus to Melanoma NCT06605417n/a2 sites📍 Marseille📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Methylomics, RNA sequencing, Spatial transcriptomics, Liquid biopsy Registry of Subjects at Risk of Pancreatic Cancer NCT04095195n/a4 sites📍 Rozzano📍 Peschiera del Garda📍 Milan Associazione Italiana per lo Studio del Pancreas · Tests: MRCP, Endoultrasonography Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi NCT06599619n/a1 site📍 Pittsburgh John Kirkwood · Tests: Single agent, adjuvant anti-PD1 therapy Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions NCT07277920n/a1 site📍 Modena University of Modena and Reggio Emilia Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis NCT07890415Phase 38 sites📍 Stanford📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: Clinical decision support tool Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) NCT05549297Phase 382 sites📍 Phoenix📍 Jacksonville📍 Orlando Immunocore Ltd · Tests: Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice BioMEL- Diagnostic and Prognostic Factors in Melanoma. NCT05446155n/a4 sites📍 Helsingborg📍 Kristianstad📍 Lund Region Skane · Tests: Imaging Sulforaphane for the Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma NCT07040280Phase 21 site📍 Pittsburgh ECOG-ACRIN Cancer Research Group · Tests: Biopsy Procedure, Biospecimen Collection, Placebo Administration, Sulforaphane
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy